Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
|
|
Sci. Signal., 20 October 2009 REVIEWSG Protein–Coupled Receptors, Cholinergic Dysfunction, and Aβ Toxicity in Alzheimers DiseaseAmantha Thathiah* and Bart De Strooper* Molecular and Developmental Genetics, VIB, Leuven, Belgium, and the Center for Human Genetics, K.U. Leuven, Leuven, Belgium. Abstract:
The β-amyloid (Aβ) peptide is associated with the pathogenesis of Alzheimers disease (AD). Evidence gathered over the last two decades suggests that the gradual accumulation of soluble and insoluble Aβ peptide species triggers a cascade of events that leads to the clinical manifestation of AD. Aβ accumulation has also been associated with the cholinergic dysfunction observed in AD, which is characterized by diminished acetylcholine release and impaired coupling of the muscarinic acetylcholine receptors (mAChRs) to heterotrimeric GTP-binding proteins (G proteins). Although the mechanism of Aβ-mediated toxicity is not clearly understood, evidence shows that Aβ accumulation has an effect on the oligomerization of the angiotensin II (AngII) AT2 (angiotensin type 2) receptor and sequestration of the G * Corresponding authors. E-mail, bart.destrooper{at}med.kuleuven.be or amantha.thathiah{at}med.kuleuven.be.
Citation: A. Thathiah, B. De Strooper, G Protein–Coupled Receptors, Cholinergic Dysfunction, and Aβ Toxicity in Alzheimers Disease. Sci. Signal. 2, re8 (2009). The editors suggest the following Related Resources on Science sites:In Science Signaling
|
Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882